feed,title,long_url,short_url
Benzinga,FDA Approves Pfizer's Tick-Borne Encephalitis Vaccine,https://benzinga.com/general/biotech/21/08/22505521/fda-approves-pfizers-tick-borne-encephalitis-vaccine,https://j.mp/37LMDwF
Benzinga,Lilly's Lebrikizumab Shows Clinical Benefit In Late-Stage Atopic Eczema Trials,https://benzinga.com/general/biotech/21/08/22505272/lillys-lebrikizumab-shows-clinical-benefit-in-late-stage-atopic-eczema-trials,https://j.mp/3xPT8JE
